Divis Laboratories tumbled 9.58% to Rs 2,954.10 after the pharmaceutical company's consolidated net profit slumped 66% to Rs 306.80 crore on 31.51% decline in revenue from operations to Rs 1,707.68 crore in Q3 FY23 over Q3 FY22.
Total income stood at Rs 1,821.93 crore in Q3 FY23, down 27.41% from Rs 2,509.86 crore recorded in the same period a year ago. Material consumption for this quarter came to be about 43% of sales revenue due to change in product mix.
Consolidated profit before tax dropped 57.86% to Rs 435.63 crore in the quarter ended 31 December 2022 as compared to Rs 1,033.66 crore posted in Q3 FY22.
Total expense decreased by 6.09% year on year to Rs 1,386.30 crore in Q3 FY23. Cost of material consumed was at Rs 604.40 crore (down 32.93% YoY) and employee benefit expenses stood at Rs 238.88 crore (down 2.35% YoY) during the period under review.
On a standalone basis, the company net profit tumbled 65.73% to Rs 310.90 crore on 31.5% fall in revenue to Rs 1,689.83 crore in Q3 FY23 over Q3 FY22.
Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Great minds don’t just skim the surface, they uncover the full story.
You’ve hit your limit of {{free_limit}} free articles this month, subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
and get complimentary access to
Smart Quarterly
₹900
3 Months
₹300/Months/month
Smart Essential
₹2700
1 Year
₹225/Months/month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Unlimited access to all articles
30+ premium stories daily, handpicked by our editor
Complimentary Access to The New York Times
News, Games, Cooking, Audio
Wirecutter & The Athletic
Complimentary Access to Our e-Paper
Digital replica of our daily newspaper
Read, save, share any article
Curated Newsletters on Diverse Topics
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Smart Investment Tips
In-depth stock analysis & insights
The Smart Investor for wealth growth tips
Access to Extensive Historical Archives
Repository of articles and publications dating back to 1997
Ad-free Reading Experience
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Repository of articles and publications dating back to 1997